Purpose Functioning is a necessary diagnostic criterion for depression, and thus routinely assessed in depressive patients. While it is highly informative of disorder severity, its change has not been tested for prognostic purposes. Our study aimed to analyze to what extent early functioning changes predict depression in the mid-term. Methods Longitudinal study (four occasions: baseline, 1, 3, and 12 months) of 243 patients with depressive symptomatology at three different services (primary care, outpatients, and hospital). Functioning was assessed on the first three occasions using the Global Assessment of Functioning (GAF), the WHODAS-2.0, and a self-reported functioning (SRF) rating scale. Growth mixture modeling of initial assessments served to estimate individual person-change parameters of each outcome. Person-growth parameters were used as predictors of major depressive episode at 12 months in a logistic regression model, adjusted by sex, age, healthcare level, and depression clinical status at third month. Predictive accuracy of all measures was assessed with area under the receiver operating curve (AUC). Results Of the 179 patients who completed all assessments, 58% had an active depression episode at baseline and 20% at 12 months (64% non-recoveries and 36% new onsets). Individual trends of change in functioning significantly predicted patient depression status a year later (AUC WHODAS = 0.76; AUC GAF = 0.92; AUC SRF = 0.93). Conclusions Longitudinal modeling of functioning was highly predictive of patients' clinical status after 1 year. Although clinical and patient-reported assessment had high prognostic value, the use of very simple patient-reported outcome measures could improve case management outside specialized psychiatric services.
Introduction
As the most prevalent mental health problem, depression is among the most significant challenges for health services. Depression affects between 10 and 20% of the general population during the lifetime [1, 2] , and increases prevalence up to a 30% [3] in primary care samples where cases are mostly encountered [4] . Time constraints and patient schedules in his setting put to a test assessment procedures for case detection and patient monitoring [5] . With such limitations, practical methods for monitoring psychiatric patients are needed for improving patient management [6] .
In total, 233 of the 243 patients completed the baseline assessment, and 179 of them completed the 12-month follow-up (74% response rate). Psychiatric outpatients had a smaller proportion of drop-outs (25%) than primary care and hospitalized patients (about 40% each). Despite this differential attrition, additional analyses did not show that loses-to-follow-up by center were significantly associated with differences in predictor or outcome variables. Most longitudinal investigations on functioning have used methods that address average group change, such as repeated methods ANOVA [7] . These methods do not allow to control within-individual effects and score autocorrelations when estimating change over time [8] . Consequently, they are not adequate to model individual patterns of change. There are few applications of longitudinal models, for modeling individual functioning trends psychiatric patients. Such modeling approach is frequent in physical and mental comorbidity studies. Longitudinal studies on functional limitations in relation to mental health are common in studies about mental health and chronic disease, conspicuously in aging studies [9] [10] [11] . However, it is far less common in psychiatry patients, where functioning is mostly treated as an indicator associated with symptoms or treatment course.
It is worth to remark that undemanding methods for appraising functioning in mental health patients have been difficult to obtain so that their use health services have been somewhat disregarded. Arguably, the traditional gold standard of functioning in mental health, the DSM-IV Global Assessment of Functioning (GAF) [9] , has been concentrated in specialized services. GAF assessment is conducted and reported by professionals and requires specialized training to evaluate patient's health status: the GAF is a prototypical example of the so-called Clinical Reported Outcomes (ClinRO [12] ). As the GAF requires substantial psychiatric training, inter-rater reliability is dependent on clinical experience [13, 14] , a barrier for professionals lacking expertise in psychiatric assessment [15] . Also, the GAF scores depend both on functioning disability and symptom severity, which deviates from guidelines of the International Classification of Functioning, that separate functioning from health status [16] . To correct this misalignment, the DSM-5 [17, 18] propose World Health Organization disability Schedule 2.0 (WHODAS 2.0) [19] , a direct report coming from patients of their own health condition without interpretation of the patient's response by a clinician or anyone else (i.e., a patient-reported outcome, PRO) [12] . The WHODAS has excellent psychometric properties [20] and is sensitive to clinical depression [21] . More recently, some research has proposed simpler one-item numerical rating scales of functioning, like those used in pain assessment [22] . PRO scales have shown good reliability and concurrence with experts' ratings [23] , as well as sensitivity to the course of symptoms [24, 25] . Given its straightforwardness, PROs methodology might be more suitable for rapid assessment of functioning in non-psychiatric services.
The importance of functioning for depression diagnosis might be also relevant for prognosis. Evidence in this regard can be helpful for providing tools for assessment and monitoring outside specialized psychiatric services. In this study, we aimed to study whether the use of early longitudinal functioning information in cases under monitoring for mood symptomatology is useful to make predictions of the course depression. As a second objective, we tried to compare the adequate method for functioning monitoring by comparing the predictive ability of ClinRo and PRO functioning assessment.
Methods

Design and sample selection
The sample was a part of the Inventory of Depression and Anxiety Symptoms (INSAyD), [24, 25] , project for studying tools for diagnosis and communication among healthcare professionals. INSAyD was an observational, prospective study (baseline, 1-, 3-and 12-month assessments) in a cohort of patients seeking help for affective distress recruited in three care levels: primary care, outpatient mental health centers, and acute psychiatric inpatient hospitals. Patients from different care levels were included to increase the range of severity close to the threshold of pathology, from subthreshold to severe. Care levels served as an initial proxy of initial patient severity that allowed, ultimately, maximizing the variety of course evolution and over time in patients.
Inclusion criteria were (a) adults older than 18 years old with demands for active affective symptomatology; (b) willing to participate in the study. Patients with psychotic symptoms, bipolar disorder, symptoms attributed to organic or substance origin, cognitive impairment (minimental state examination < 24 points [26] ), life expectancy under 6 months or language problems were excluded. Participation was offered to 327 patients that met inclusion criteria, and 243 consented to participate (74% response rate).
Procedures
Patients were invited to participate by health professionals and then informed by a certified trained psychologist of the nature and methods of the study. After signing informed consent, patients were assessed in person and scheduled for follow-up after baseline evaluation. After a year, a trained clinician conducted a phone interview as a final assessment. Patients were considered drop-outs if they missed any follow-up appointment and could not be reached by phone after five attempts. Details on the study are provided elsewhere [25] .
Clinical diagnosis
Psychopathology at baseline was assessed using MINIInternational Neuropsychiatric Interview 5.0 (MINI) [27] . Given time constraints, we included only the sections major depression episode (MDE), and dysthymia, bipolar disorder, panic disorder, generalized anxiety disorder (GAD), and suicide risk. Depression was tracked at baseline and follow-ups using the Patient Health Questionnaire 9 (PHQ-9) [28] . The PHQ9 is interpretable according to DSM criteria using the following diagnostic algorithm [29] (at least five items answered as "more than half the days" or "nearly every day," and suicidal ideation whenever the response is different from "never"). The PHQ-9 has excellent reliability, validity, and diagnostic accuracy and over 90% diagnostic accuracy when compared to the MINI [30] .
Clinical and Patient-Reported Outcomes Assessment
ClinRO assessment of functioning was conducted using DSM-IV axis V criteria with the Spanish version of the Global Assessment of Functioning [31] , scoring from 0 to 100 from total disability to superior functioning. The GAF uses 10-point tabulation guidelines for decision; at each level, the decision considers the worst of either symptom severity or functioning, and the GAF examinations stop at the 10-point interval where both constructs meet the criteria.
Sociodemographic variables were gathered during the clinical interview: age (in years), gender, nationality, education level (primary, secondary, and higher college education), employment status (employed, unemployed, or other situations), and civil status (married or living with partner, divorced, or separated, and widowed). Clinical assessment included information regarding comorbid physical conditions extracted from clinical record [32] . Given the low frequency of individual conditions, comorbidities were treated as counts of concurrent conditions in a patient.
We used two methods of PRO assessment. Firstly, the 12-item Spanish version of the World Health Organization Disability Assessment Scale 2.0 (WHODAS 2.0) [33] , with scores into a 0 (highest) to 100 (lower) functioning (i.e., higher disability). The second PRO was self-reported functioning (SRF) using a one-item numerical rating scale. The SRF asks the patient: "On a scale from 0 (lowest) to 100, (highest) how you would currently rate your overall level of functioning?" This procedure has shown good discriminant and criterion validity for detecting MDE [22] [23] [24] .
All three methods are transformed into a 0-100 scale so that a different scaling was not a source of heterogeneity.
Statistical analysis
We computed descriptive statistics of the sample and score change during the follow-ups. Instrument test-retest reliability in a group of stable patients during the first month was computed using two-way random effects intraclass correlation coefficient for absolute agreement in multiple measurements.
Analyses followed a two-tier modeling process, depicted in Fig. 1 using path diagrammatic conventions. As a first step (continuous lines in Fig. 1 ), we fitted a growth mixture model (GMM) for estimation of person-evolution parameters. In a second step (dashed lines in Fig. 1 ), parameters predicted 12-month depression in a logistic regression model.
Growth mixture modeling of functioning changes
We modeled individual early functioning trends (baseline to third follow-up), using GMM, a case-centered modeling that allows estimating intra-individual and interindividual variability in longitudinal assessments [34] . GMM describes person evolution with two parameters (see Fig. 1 ): intercept (i), which represents starting values, and slope (s), the rate of change over time. Parameters can be understood as trend-scores describing rate of change in functioning, adjusted by patient's baseline functioning. The model included correlation between i and s to control association between initial functioning and its evolution, thus accounting for effects such as regression towards the mean (i.e., more severe cases are prone to steeper recoveries).
As not all patients departed from initial levels of severity, the model was tested for sample inter-subject heterogeneity inferring the presence of homogeneous latent subgroups c in the sample. Model estimation began with a single-cluster model (i.e., all groups share an overall trajectory), then adding clusters for each succesive model (i.e., subgroups with specific trajectories). The final number of subgroups c was decided using the following criteria: more than 10% subjects in the smallest cluster; not-significant Lo-Mendell-Rubin likelihood ratio test (adjusted LMR_LRT) between c and c+1 clusters, and lowest value in Bayesian Information Criteria (BIC) [35] . Estimation was conducted using full information maximum likelihood (FIML). This approach has been to have adequate power for detecting classes and significant trends in samples as small as 150-200 cases [8, 35, 36] .
Slopes were scaled in months to indicate the rate of monthly change in functioning. As only three-time points were available, and to avoid model overfitting, we did not attempt to model curvilinear trends over time.
Prediction of 12-month status using person parameters of functioning change
To determine the predictive ability of individual early functioning trajectories on patient depression status at 12 months, individual parameters i n and s k were introduced as predictors of MDE 12-month status in binary logistic regression models. Predictive models were estimated using a nested approach. Six models were estimated: three methods of assessment (GAF, WHODAS, and SRF), with and without adjustment by disorder status at third month. Functioning measures were treated as continuous predictors of MDE status as a dichotomous outcome (active/inactive). Models were adjusted for age, number of comorbid chronic conditions, and the presence of mental comorbidity (as assessed by MINI), health setting (primary care, outpatient, and hospital), and gender (see Fig. 1 ). We obtained significance of model parameters and odds ratios (ORs) using Wald's test. Fit was assessed using Nagelkerke's Pseudo R-squared and Hosmer-Lemeshow fit test using eight groups.
We tested predictive accuracy of the logistic model using Area under the receiver operating curve (AUC) using 12-month MDE status as status variable. AUCs and classification accuracy statistics of model-expected probabilities at Youden's Index: sensitivity, specificity, positive and negative predictive values, and positive and negative likelihood ratios. Predictive analyses used a tenfold cross-validation sample to avoid overfitting. For comparability, we inverted the direction of WHODAS (which, opposite to the GAF and SRF, reflects worse functioning in higher scores). We expected that ORs would be below 1, indicating that increasing functioning lowers the likelihood of disorder.
Missing data handling
Growth models and LR were estimated using FIML, thus accounting for missing data across time [37] . For ROC and predictive accuracy analyses, we applied multiple imputation using the fully conditional specification method via Markov Chain Monte Carlo (FCS-MCMC), with five imputed datasets for pooled analyses [38] with 2000 randomly chosen starting values. Both in FIML and FCS-MCMC, values were imputed for missingness according to the presence of at least one point of longitudinal information, so that ten cases with all missing data during the follow-up were dropped from the analysis. Sensitivity analyses showed that excluding individuals with missing data resulted in similar cluster structure estimates.
Analyses were conducted using MPlus 7.2 and SPSS 20.0.
Results
In total, 233 of the 243 patients completed the baseline assessment, and 179 of them completed the 12-month follow-up (74% response rate). Psychiatric outpatients had a smaller proportion of drop-outs (25%) than primary care and hospitalized patients (about 40% each). Despite this differential attrition, additional analyses did not show that loses-to-follow-up by center were significantly associated with differences in predictor or outcome variables. The average age was 49.1 years old (SD = 14.8), and 69% were women; 58% cases fulfilled DSM-5 symptom criteria for active MDE symptomatology at baseline, 56% of them with comorbid mental disorders (generalized anxiety, panic, or dysthymia). The average number of physical conditions was 1.13 (SD = 1). Table 1 shows sample descriptives at baseline.
As seen in Table 2 , MDE prevalence significantly decayed over time (F 1,139 =30.36, p = < 0.00), from 57.9 to 21%. From the 20% patients with MDE at 12 months, 64% (n = 23) showed no recovery during the first 3 months, while the remaining 36% (n = 14) were new onsets during Table 3 shows GMM selection and parameters. For all measures, the c = 1 class solution was preferred over solutions with more classes. The two-class solution had either very low frequencies in the smallest cluster (GAF = 2.8%; WHODAS = 49.2%; SRF = 3.2%) or a non-significant LMR_LRT over the one clusters solutions (GAF 17. Table 3 shows good fit of the onecluster model according to Chi-square, and standardized root mean squared residual, indicating the homogeneous variability of the functioning change. As there was no sign of substantial heterogeneity in patient change profiles, the sample was treated as a homogenous group.
The GAF showed the highest standardized intercept value (5.51) and WHODAS the lowest deviation from average (3.0). Slopes showed change towards functioning recovery in all measures (GAF 1.97 points/month; WHO-DAS = − 1.14 points/month; SRF = 2.43 points/month). Notice that, given WHODAS scaling, higher values reflect greater disability, its slope was negative. Standardized slopes of the GAF showed the fastest change rate (0.57), followed by WHODAS (− 0.47), and SRF (0.36). Intercept and slopes were negatively correlated (r isGAF = − 0.47; r isWHODAS = − .32; r isSRF = − .45 in SRF), indicating steepest that functioning recovery was steeper in cases lower functioning levels at baseline, a sign of regression towards the mean. The final GMM explained a large number of indicator variances across occasions, with a minimum of 51% (first-month SRF) and a maximum of 87% (thirdmonth SRF). Table 4 shows that MDE status at the third month significantly increased the likelihood of active MDE symptomatology at 12 months (OR = 11.19). However, when functioning was considered, third-month MDE became non-significant (GAF and SRF) or was substantial (WHODAS OR = 5.84). For all measures, a higher intercept value (indicative of better functioning at baseline) indicated a reduced likelihood of 12-month MDE. The GAF was highly predictive of 12-month MDE symptoms (OR = 0.73), followed by SRF (OR = 2.09). Models indicated that 1-point differences in the slope parameter, (indicative of steeper patient improvement) predicted lower probabilities of active MDE at 12 months. Changes in self-reported measures were likely to predict 12-month symptomatology (GAF OR = 0.14; SRF = 0.40), Table 2 Descriptives of functioning measures at baseline and follow-ups but slope was not significant in the case of the WHODAS (OR = 1.16, p = 0.62). Figure 2 compares the predictive ability of each measure using the ROC curves in the cross-validation, with and without considering the MDE status at the third month.
AUCs indicated that person functioning trends, as assessed with the three methods, were accurate predictors of MDE symptom status at 12 months. Active MDE at the third month associated with MDE 12-month status (AUC 
Discussion
Assessment of functioning disability is compulsory for diagnosing depression, and a key outcome for defining remission. In this study, we investigated whether initial changes of ClinRO and PRO measures of functioning (WHODAS2.0 and SRF) predicted patient depression status after a year, using GMM, a method specifically devised to capture individual information in change trends.
Our study indicates that tracking functioning disability is useful for predicting the course of clinical depression. In isolation from other mental health information, ClinRO and PRO functioning measures achieved predictions of 12-month clinical status with AUCs over 0.75. Functioning evolution trends predicted remissions, but also new onsets in patients with initial affective distress but without an active MDE diagnosis. Adding information about patient's MDE status at the third month did not increase prediction accuracy: conditional on patients' initial severity, functioning disability trends contained sufficient information for prognosis (Table 5) .
Results must be interpreted in the light of their limitations. First, the sample is composed of patients seeking health care for mental symptomatology, all of them underwent at least minimally adequate treatment [39] . Therefore, our results cannot be generalized to non-treated cases. Also, the fact that all cases had some level of symptomatology, impeded us to provide diagnostic cut-offs. However, recruitment in this study was representative of the clinical course of patients who demand attention for affective distress. Secondly, it is important to highlight that the INSAyD cohort was devised to maximize initial patient severity so that different courses of illness could be found during the follow-up. Our results do not imply that depression has a homogeneous course. On the contrary, correlated intercepts i and slopes s assumed that individual course is not independent of severity. Thus, the most proper model interpretation would be that functioning trends in our sample were homogeneous when adjusted by level of baseline functioning. Thirdly, the use of only three follow-ups impeded modeling non-linearity in recovery, which is initially steeper; this would result in underestimation of the explained variance of change. Also, notice that the 12-month follow-up was not included in the GMM, as it was concurrent with MDE status at 12 months. Even though including 12-month functioning would allow describing quadratic trends of recovery, the clinical and functioning status at 12 months would be simultaneous, precluding the predictive hypothesis that was the objective of this work. The usefulness of concurrent measures of functioning for screening MDE was treated elsewhere [24] . Finally, we did not consider individual symptoms as predictors of depression course. We controlled the symptom effects by controlling for third-month MDE status, given that evidence indicates that individual symptom trends are predictive of depression course [40] .
At the same time, our study design has some strengths. We measured and compared functioning disability with two gold standard instruments: the traditional clinical GAF proposed in the DSM-IV and the more recent WHODAS proposed in the DSM-5. To our knowledge, this is the first comparison of these instruments in a longitudinal design with patients seeking health care: a case that confronts two assessment approaches (ClinRO vs. PROs) in a naturalistic situation regarding the patient demands. Also, the 12-month period permits avoiding the lag between symptom and functioning recovery [41] .
The model provides evidence that, once patients are followed for emotional distress, the evolution of functioning during early patient monitoring allows predicting their symptoms after 12 months. Our result adds to previous evidence about the usefulness of functioning assessment in MDE and the interrelatedness of subjective functioning and affective distress [21, 42] . Functioning disability has been pointed as an endpoint of patient treatment [6, 15] , and as a method for guiding treatment [5, 41, 43] . However, beyond PROs and ClinROs as outcomes, this study found that quantitatively accrued information on patient's self-perceived changes serves for prognosis. In a previous study, Moos et al. [7] found no evidence of the usefulness of the GAF for this objective. However, their analytic approach focused on average change and did not extract information on within-individual measures. In our study, a growth model, an explicitly longitudinal technique, models the rate of individual change, something that is not possible with ANOVA-like techniques. Just for comparison, we devised a logistic regression model including functioning scores (not person trends) at baseline, first and third, and MDE at third month. In such model, only third-month MDE status was a significant predictor, with AUCs between 0.74 (for WHO-DAS) and 0.78 (for GAF). The lower predictive ability is a consequence of a well-known property that motivates longitudinal modeling [8] : the contribution of within-individual information to a within-subjects repeated measurement. These results hint to a promising line of research in PROs predictors of health outcomes. The application of longitudinal models allows going from patient's snapshots to patient's dynamics, which results in much higher predictive ability. An unexpected result was that individual trends of GAF and SRF outperformed WHODAS, which was less sensitive to patient changes during the follow-up for prognosis. The WHODAS physical disability contents may be adding noise when it comes to assessing mental health functioning. Physical limitations only influence depression functioning in the most severe cases [21] , so these contents might render the WHODAS unspecific for mild or moderate depressions. A second difference is that the WHODAS is an instrument with norm-based scores. Despite using just one indicator to decide, the GAF and SRF tasks have nuances that may lead to higher responsiveness to clinical change.
We consider that the different predictive ability of the methods is a relevant result. Not all methods are equally feasible in all health settings: self-reported methods (SRF and WHODAS) are easy to apply and require no training, rendering them adequate in non-specialized services. On the contrary, the clinical method (GAF) requires extensive training and experience in psychiatric assessment. The GAF mixes the assessment of pure functioning impairment with an expert assessment of symptom severity. While this is a construct validity issue that has been criticized [44] , the overlap between functioning and symptoms can be of advantage when predicting clinical course. As for the SRF, patients are likely assessing the rate at which they are coming close to their functioning standards, the satisfaction with the rhythm of recovery and, ultimately, with treatment results. There is evidence that patients' impressions of their status use historical information about themselves as a reference for providing scores [45, 46] .
Conclusions
Using patient-reported health status for targeting interventions in specific patient populations is an increasingly recommended practice [47] . PRO measures might be suitable for mental health management [24, 48] . A highly predictive monitoring would allow clinicians to anticipate patient aggravation and chronification, which might lead to more personalized interventions.
Taking advantage of longitudinal of PRO information is promising in this regard and aligns with other evidence pointing at the potential of PROs for mental health assessment in settings with pressing demands [43, 49] . It is not likely that PROs provide reliable measures in other mental health disorders, especially when they course with low awareness, confusional states, or impaired understanding, such as in psychosis or substance use.
